Effect of Caerulein with Haloperidol on Monoamine Contents in Rat Brain Regions Treated with Methamphetamine
Author(s) -
Miyuki Hashimoto,
Takafumi Hirai,
Katsuji Oguchi,
Hajime Yasuhara
Publication year - 1986
Publication title -
the japanese journal of pharmacology
Language(s) - English
Resource type - Journals
eISSN - 1347-3506
pISSN - 0021-5198
DOI - 10.1254/jjp.41.127
Subject(s) - methamphetamine , haloperidol , monoamine neurotransmitter , dopamine , serotonin , chemistry , endocrinology , medicine , pharmacology , amphetamine , receptor
To elucidate the mechanism of the antagonistic effect of caerulein on amphetamine-induced hyperactivity, monoamine contents in rat brain regions were measured by HPLC. With a combination of caerulein and haloperidol, dopamine contents in methamphetamine treated-rats were significantly decreased in the striatum. Noradrenaline contents were significantly decreased in the haloperidol-methamphetamine group, but caerulein restored it to the normal levels. Serotonin contents did not change in any of the groups tested. These results may indicate that caerulein acts as a neuromodulator in rat brain and causes suppression of hyperactivity induced by methamphetamine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom